12 April 2021: Clinical Research
Prostate Adenocarcinoma with Brain Metastasis: A Surveillance, Epidemiology, and End Results Database Analysis 2010–2015
Zin W. Myint ABCDEF* , Ayman H. Qasrawi ABCDEFDOI: 10.12659/MSM.930064
Med Sci Monit 2021; 27:e930064
Table 2 Univariate and multivariate analysis of variables associated with prostate brain metastasis.
| Variables | Univariate | Multivariate | ||
|---|---|---|---|---|
| Odds ratio (95% CI) | P value | Odds ratio (95% CI) | P value | |
| Liver metastasis | 5.38 (3.7–7.8) | 2.85 (1.9–4.3) | ||
| Lung metastasis | 5.96 (4.4–8.0) | 4.62 (3.3–6.4) | ||
| Age ≤75 | 1.38 (1–1.9) | 0.05 | ||
| Race | 0.95 (0.7–1.3) | 0.8 | ||
| Chemotherapy | 0.76 (0.5–1.2) | 0.2 | ||
| Bone metastasis | 1.36 (0.9–2.1) | 0.2 | ||